Zhao W - Search Results

1

Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy.

Zhao W, Zheng XL, Jiang ZN, Liao XB, Zhao SP. Zhao W, et al. Among authors: zhao sp. Int J Cardiol. 2017 Dec 1;248:355-360. doi: 10.1016/j.ijcard.2017.06.105. Epub 2017 Jun 30. Int J Cardiol. 2017. PMID: 28689987

2

The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature.

Zhao W, Xiao ZJ, Zhao SP. Zhao W, et al. Among authors: zhao sp. Neurol India. 2019 Jul-Aug;67(4):983-992. doi: 10.4103/0028-3886.266274. Neurol India. 2019. PMID: 31512619 Free article. Review.

3

[Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats].

HUANG XS, ZHAO SP, BAI L, ZHANG Q, HU M, ZHAO W. HUANG XS, et al. Among authors: zhao w, zhao sp. Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Sep;38(9):809-13. Zhonghua Xin Xue Guan Bing Za Zhi. 2010. PMID: 21092650 Chinese.

4

MicroRNA-143/-145 in Cardiovascular Diseases.

Zhao W, Zhao SP, Zhao YH. Zhao W, et al. Among authors: zhao yh, zhao sp. Biomed Res Int. 2015;2015:531740. doi: 10.1155/2015/531740. Epub 2015 Jun 28. Biomed Res Int. 2015. PMID: 26221598 Free PMC article. Review.

5

Different effects of statins on induction of diabetes mellitus: an experimental study.

Zhao W, Zhao SP. Zhao W, et al. Among authors: zhao sp. Drug Des Devel Ther. 2015 Nov 24;9:6211-23. doi: 10.2147/DDDT.S87979. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26648697 Free PMC article.

6

The Role of Overexpressed Apolipoprotein AV in Insulin-Resistant Hepatocytes.

Zhao W, Liu Y, Liao X, Zhao S. Zhao W, et al. Among authors: zhao s. Biomed Res Int. 2020 Apr 21;2020:3268505. doi: 10.1155/2020/3268505. eCollection 2020. Biomed Res Int. 2020. PMID: 32382544 Free PMC article.

7

Potential Regulatory Role of lncRNA-miRNA-mRNA in Coronary Artery Disease (CAD).

Zhu L, Zhao S, Zhao W. Zhu L, et al. Among authors: zhao w, zhao s. Int Heart J. 2021 Nov 30;62(6):1369-1378. doi: 10.1536/ihj.21-156. Epub 2021 Nov 17. Int Heart J. 2021. PMID: 34789641 Free article.

8

Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.

Huang XS, Zhao SP, Bai L, Hu M, Zhao W, Zhang Q. Huang XS, et al. Among authors: zhao w, zhao sp. Br J Pharmacol. 2009 Oct;158(3):706-12. doi: 10.1111/j.1476-5381.2009.00350.x. Epub 2009 Aug 19. Br J Pharmacol. 2009. PMID: 19694729 Free PMC article.

9

[Increased serum apolipoprotein A5 in patients with acute coronary syndrome].

Huang XS, Zhao SP, Zhang Q, Bai L, Hu M, Zhao W. Huang XS, et al. Among authors: zhao w, zhao sp. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Oct;37(10):896-9. Zhonghua Xin Xue Guan Bing Za Zhi. 2009. PMID: 20137539 Chinese.

10

The effects of myocyte enhancer factor 2A gene on the proliferation, migration and phenotype of vascular smooth muscle cells.

Zhao W, Zhao SP, Peng DQ. Zhao W, et al. Among authors: zhao sp. Cell Biochem Funct. 2012 Mar;30(2):108-13. doi: 10.1002/cbf.1823. Epub 2011 Oct 26. Cell Biochem Funct. 2012. PMID: 22028303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,705 results

Search Page

Filters